In the last 12 months, insiders at Ayala Pharmaceuticals, Inc. ($ADXS) filed 20 transactions with the SEC: 0 open-market purchases totaling $0 and 0 sales totaling $0. Net insider sentiment: neutral.
Ayala Pharmaceuticals, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Israel Biotech Fund I, L.P. (Director) — 20 transactions totaling $17,738,440
View all SEC Filings for Ayala Pharmaceuticals, Inc. (ADXS).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 1, 2024 | Israel Biotech Fund I, L.P. | Director | M | Rights | 3750000 | $0.00 | 4,087,500.0000 | 0 | 47.85% | 0.00% |
| March 1, 2024 | Israel Biotech Fund I, L.P. | Director | M | Rights | 3750000 | $0.00 | 9,712,500.0000 | 0 | 27.86% | 0.00% |
| March 1, 2024 | Israel Biotech Fund I, L.P. | Director | M | Convertible Promissory Note | 1500000 | $0.00 | 5,587,500.0000 | 0 | 36.70% | 0.00% |
| March 1, 2024 | Israel Biotech Fund I, L.P. | Director | M | Convertible Promissory Note | 1500000 | $0.00 | 11,212,500.0000 | 0 | 15.44% | 0.00% |
| March 1, 2024 | Israel Biotech Fund I, L.P. | Director | M | Warrants | 2250000 | $0.00 | 7,837,500.0000 | 0 | 40.27% | 0.00% |
| March 1, 2024 | Israel Biotech Fund I, L.P. | Director | M | Warrants | 2250000 | $0.00 | 13,462,500.0000 | 0 | 20.07% | 0.00% |
| Feb. 7, 2024 | Israel Biotech Fund I, L.P. | Director | M | Common Stock, par value $0.001 per share | 1926221 | $0.40 | 11,044,282.0000 | 0 | 21.13% | 0.00% |
| Feb. 7, 2024 | Israel Biotech Fund I, L.P. | Director | M | Common Stock, par value $0.001 per share | 4237687 | $0.40 | 18,359,495.0000 | 0 | 30.01% | 0.00% |
| Feb. 7, 2024 | Israel Biotech Fund I, L.P. | Director | M | Common Stock, par value $0.001 per share | 3887438 | $0.40 | 14,931,720.0000 | 0 | 35.20% | 0.00% |
| Feb. 7, 2024 | Israel Biotech Fund I, L.P. | Director | M | Common Stock, par value $0.001 per share | 1295813 | $0.40 | 19,655,308.0000 | 0 | 7.06% | 0.00% |
| Feb. 7, 2024 | Israel Biotech Fund I, L.P. | Director | M | Common Stock, par value $0.001 per share | 8437500 | $0.40 | 23,369,220.0000 | 0 | 56.51% | 0.00% |
| Feb. 7, 2024 | Israel Biotech Fund I, L.P. | Director | F | Common Stock, par value $0.001 per share | 2707581 | $1.25 | 20,661,639.0000 | 0 | 11.59% | 0.00% |
| Feb. 7, 2024 | Israel Biotech Fund I, L.P. | Director | M | Common Stock, par value $0.001 per share | 8062500 | $0.40 | 27,717,808.0000 | 0 | 41.02% | 0.00% |
| Feb. 7, 2024 | Israel Biotech Fund I, L.P. | Director | F | Common Stock, par value $0.001 per share | 2586905 | $1.25 | 25,130,903.0000 | 0 | 9.33% | 0.00% |
| Feb. 7, 2024 | Israel Biotech Fund I, L.P. | Director | M | Convertible Promissory Note | 1926221 | $0.00 | 13,661,159.0000 | 0 | 12.36% | 0.00% |
| Feb. 7, 2024 | Israel Biotech Fund I, L.P. | Director | M | Convertible Promissory Note | 4237687 | $0.00 | 18,996,000.0000 | 0 | 18.24% | 0.00% |
| Feb. 7, 2024 | Israel Biotech Fund I, L.P. | Director | M | Convertible Promissory Note | 3887438 | $0.00 | 11,724,938.0000 | 0 | 24.90% | 0.00% |
| Feb. 7, 2024 | Israel Biotech Fund I, L.P. | Director | M | Convertible Promissory Note | 1295813 | $0.00 | 14,758,313.0000 | 0 | 8.07% | 0.00% |
| Feb. 7, 2024 | Israel Biotech Fund I, L.P. | Director | M | Warrants | 8437500 | $0.00 | 7,837,500.0000 | 0 | 51.84% | 0.00% |
| Feb. 7, 2024 | Israel Biotech Fund I, L.P. | Director | M | Warrants | 8062500 | $0.00 | 13,462,500.0000 | 0 | 37.46% | 0.00% |